At The Micron Group, we support your product’s clinical development from First-in-Human (FIH) trials through to regulatory approval, offering specialised early-phase clinical trial services.
Our team has deep expertise in managing first-in-human studies, with a focus on dose escalation strategies, patient safety monitoring, and generating early safety data. These trials are designed to deliver critical insights and support data-driven go/no-go decisions.
Data-driven go/no-go decisions begin with expertly managed FIH trials.
109B Lancaster Way Business Park
CB6 3NX, Ely, Cambridgeshire
England, United Kingdom
12022 Blue Valley Parkway, Overland Park
Kansas 66213, United States of America
5 Regency Drive, Building C, Route 21 Corporate Park Irene, South Africa
Harju maakond, Tallinn, Kesklinna linnaosa
Viru väljak 2, Tallinn 10111, Estonia
9 Regency Drive, Building B, Route 21 Corporate Park
Irene, 0157, South Africa